|
BASKING RIDGE, N.J., June 1, 2005 -- Hooper Holmes, Inc. (HH) announced today that Maria Caamano has joined the Company as the Director of New Business Development, Pharmaceutical Services.
Ms. Caamano, with an M.B.A. in Health Systems Management, brings a background in strategic business planning and development in the large physician practice environment and in clinical trial management at the investigative level. In her role, Ms. Caamano will be focusing on product/strategic planning and new business development with specific focus in clinical trials, post-approval monitoring, and related activities in occupational health.
Jim McNamee, Chairman, President and Chief Executive Officer of Hooper Holmes, commented, "The addition of Ms. Caamano to the Company's initiative in the pharmaceutical market demonstrates Hooper Holmes' ongoing commitment to develop services for the Contract Research Organization (CRO) and pharmaceutical markets, primarily in Phase III and the potentially changing world of Phase IV studies."
About Hooper Holmes, Inc.:
Hooper Holmes provides outsourced risk assessment services to the life insurance industry through over 265 locations nationwide and in the United Kingdom, as well as claims evaluation information services to the automobile, and workers' compensation insurance industries.
Contact:
Hooper Holmes, Inc.
Fred Lash, Chief Financial Officer of Hooper Holmes, Inc.
+1-908-766-5000
or
Investors - Jonathan Birt or John Capodanno
or Media - Sean Leous, all of Financial Dynamics
+1-212-850-5600, for Hooper Holmes, Inc.
|